Articles

Golfer who won $1.5 million knew he wouldn’t be able to keep it. Here’s why he played anyway.

Nick Dunlap can now accept a PGA Tour card and turn pro — or stay in college.

U.S. stock-market earnings ‘unlikely to escape a slowdown unscathed’

Investors in the U.S. stock market should “maintain a defensive posture,” as company earnings risk falling under “near-term pressure,” according to Wells Fargo Investment Institute.

Shares of SPAC buying Trump Media have more than tripled during record win streak

The stock's rocket ride comes as Trump is set to take the next step toward winning the GOP nomination.

Oil traders care more about North Dakota weather than Red Sea missile attacks

The weather in North Dakota has managed to do what Houthi rebels operating in the Red Sea have failed to --- disrupt the supply of oil.

Recession red flags: Wall Street and Main Street are at odds about the economy

It isn't healthy for Wall Street to be celebrating when so many consumers are gloomy.

New Nasdaq tool suggests the IPO market will be in an uptrend for the next six months

The Nasdaq IPO Pulse Index seeks to show the trend in the market before the actual data changes. The good news is that it's currently signaling an uptrend through the first half of the year.

Here’s the No. 1 question retail investors want Tesla to answer ahead of earnings

Amid hundreds of questions for Tesla earnings day, one reigns supreme.

Landlord debt is rallying — even in the battered office sector

Debt issued by publicly traded commercial real-estate landlords has been in rally mode to start 2024, even in the battered office sector.

Small-cap stocks had a rough start to 2024 — but could shine the rest of this year, says stock market’s biggest bull

Small-cap stocks have had a rough start to 2024 so far, but they could still shine over the rest of this year, according to Tom Lee, an equity bull and head of research at Fundstrat Global Advisors.

Eli Lilly gene therapy allows child born deaf to hear, clinical trial shows

An Eli Lilly experimental gene therapy has restored the hearing of a child who was born deaf.

D.R. Horton’s stock dives as lower prices for new homes hurt profits

Shares of D.R. Horton Inc. were suffering the biggest selloff in nearly four years on Tuesday, after the homebuilder missed profit expectations, as elevated incentives to buy new homes ate into margins.

How biotech billionaire Patrick Soon-Shiong got in over his head at the LA Times

Soon-Shiong believed investing in the paper was a civic duty, but after years of steep losses, his appetite for spending seems to be running out.
1 1,682 1,683 1,684 1,685 1,686 2,454